Genesis Energy, L.P. Declares Quarterly Distribution

HOUSTON--(BUSINESS WIRE)-- Genesis Energy, L.P. (NYSE: GEL) announced today that, on July 16, 2018, the Board of Directors of its general partner declared a distribution on Genesis’ common units and 8.75% Class A Convertible Preferred Units attributable to the quarter ended June 30, 2018. These distributions will be paid on August 14, 2018 to holders of record at the close of business on July 31, 2018.

Each holder of common units will be paid a quarterly cash distribution of $0.53 ($2.12 on an annualized basis) for each common unit held of record. With respect to the preferred units, Genesis declared a payment-in-kind of the quarterly distribution resulting in the issuance of an additional approximately 511,934 preferred units (“PIK units”). Each holder of a preferred unit will be paid through the issuance of 0.021875 PIK units (plus cash for any fractional unit based on $33.71 per unit) for each preferred unit held of record. This distribution equates to a quarterly distribution of $0.7374 per preferred unit ($2.9496 on an annualized basis). The PIK units will be issued in book-entry form on the payment date.

Genesis Energy, L.P. is a diversified midstream energy master limited partnership headquartered in Houston, Texas. Genesis’ operations include offshore pipeline transportation, sodium minerals and sulfur services, marine transportation and onshore facilities and transportation (formerly known as supply and logistics). Genesis’ operations are primarily located in Texas, Louisiana, Arkansas, Mississippi, Alabama, Florida, Wyoming and the Gulf of Mexico.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180717005047/en/

Genesis Energy, L.P.
Bob Deere, (713) 860-2516
Chief Financial Officer

Source: Genesis Energy, L.P.

You May Also Be Interested In

• Aartech Canada Named Canadian Distributor for TAKEX America Security Sensing Technologies
• Manhattan 24 Hour Live-In Care Swaps Fear for Peace of Mind at Touching Hearts at Home NYC
• Aizen Enters into Collaboration with San Diego Biopharma to Advance Oral Biologics